Chemed Corporation (NYSE:CHE) Given Average Rating of “Moderate Buy” by Brokerages

Chemed Corporation (NYSE:CHE) has been given a consensus recommendation of “Moderate Buy” by the six brokerages that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $574.25.

Several research analysts have recently weighed in on CHE shares. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, October 8th. Bank of America lowered their price target on Chemed from $610.00 to $595.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th. Jefferies Financial Group upgraded Chemed from a “hold” rating to a “buy” rating and lifted their target price for the stock from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Finally, Royal Bank Of Canada reduced their price objective on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, November 10th.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, September 26th. The shares were sold at an average price of $461.28, for a total transaction of $1,383,840.00. Following the completion of the sale, the chief executive officer directly owned 96,197 shares in the company, valued at $44,373,752.16. This trade represents a 3.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 3.29% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Chemed

Large investors have recently made changes to their positions in the company. Allworth Financial LP grew its holdings in Chemed by 59.0% in the 3rd quarter. Allworth Financial LP now owns 299 shares of the company’s stock valued at $134,000 after buying an additional 111 shares in the last quarter. IFP Advisors Inc boosted its position in shares of Chemed by 56.8% in the third quarter. IFP Advisors Inc now owns 872 shares of the company’s stock valued at $390,000 after acquiring an additional 316 shares during the period. Swiss Life Asset Management Ltd acquired a new position in shares of Chemed in the third quarter valued at about $304,000. WBI Investments LLC acquired a new position in shares of Chemed in the third quarter valued at about $2,364,000. Finally, Caitong International Asset Management Co. Ltd increased its position in Chemed by 5,333.3% during the third quarter. Caitong International Asset Management Co. Ltd now owns 163 shares of the company’s stock worth $73,000 after acquiring an additional 160 shares during the period. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

Shares of NYSE CHE opened at $432.30 on Wednesday. The stock has a 50 day moving average price of $435.59 and a 200 day moving average price of $456.51. The stock has a market capitalization of $6.12 billion, a PE ratio of 22.86, a price-to-earnings-growth ratio of 2.43 and a beta of 0.46. Chemed has a 52 week low of $408.42 and a 52 week high of $623.60.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, October 28th. The company reported $5.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The company had revenue of $624.90 million for the quarter, compared to the consensus estimate of $626.04 million. During the same quarter in the prior year, the company earned $5.64 EPS. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, research analysts forecast that Chemed will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were paid a $0.60 dividend. The ex-dividend date was Monday, November 17th. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s dividend payout ratio is 12.69%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.